Izotropic (TSE:IZO) has released an update.
Izotropic Corporation, a medical device company specializing in breast CT imaging systems, has restructured its loan terms with its primary lender, leading to an amended principal sum of $2,415,000 with a new maturity date set for September 30, 2024. This revised loan includes accumulated interest and extension fees, with the company having already paid $325,000 in interest payments.
For further insights into TSE:IZO stock, check out TipRanks’ Stock Analysis page.
